Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Breban

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Joint Bone Spine|January 26, 2002
Nitric oxide in rheumatologyC Bernardeau, E Dernis-Labous, H Blanchard, et al.
Infection and Immunity|July 23, 1999
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic ratG Falgarone, H S Blanchard, B Riot, et al.
Clinical Rheumatology|September 1, 1991
The actual survival rate in systemic lupus erythematosus: study of a 1976 cohortM Breban, O Meyer, P Bourgeois, et al.
Arthritis Research & Therapy|July 17, 2021
Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritisL M Araujo, Q Jouhault, I Fert, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alphaF Allali, M Breban, R Porcher, et al.
Rheumatology (Oxford, England)|July 13, 1999
Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel diseaseA El Maghraoui, M Dougados, E Freneaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expressionJ D Taurog, S D Maika, W A Simmons, et al.
Annals of the Rheumatic Diseases|April 17, 2008
Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional studyE Dernis, R Said-Nahal, M-A D'Agostino, et al.
The Journal of Rheumatology|February 1, 1992
Protective effects of ciprofloxacin against type II collagen induced arthritis in ratsM Breban, C Fournier, M A Gougerot-Pocidalo, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Defective dendritic cell (DC) function in a HLA-B27 transgenic rat model of spondyloarthropathy (SpA)A J Stagg, M Breban, R E Hammer, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Joint Bone Spine|January 26, 2002
Nitric oxide in rheumatologyC Bernardeau, E Dernis-Labous, H Blanchard, et al.
Infection and Immunity|July 23, 1999
Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic ratG Falgarone, H S Blanchard, B Riot, et al.
Clinical Rheumatology|September 1, 1991
The actual survival rate in systemic lupus erythematosus: study of a 1976 cohortM Breban, O Meyer, P Bourgeois, et al.
Arthritis Research & Therapy|July 17, 2021
Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritisL M Araujo, Q Jouhault, I Fert, et al.
Annals of the Rheumatic Diseases|March 14, 2003
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alphaF Allali, M Breban, R Porcher, et al.
Rheumatology (Oxford, England)|July 13, 1999
Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel diseaseA El Maghraoui, M Dougados, E Freneaux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1993
Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expressionJ D Taurog, S D Maika, W A Simmons, et al.
Annals of the Rheumatic Diseases|April 17, 2008
Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional studyE Dernis, R Said-Nahal, M-A D'Agostino, et al.
The Journal of Rheumatology|February 1, 1992
Protective effects of ciprofloxacin against type II collagen induced arthritis in ratsM Breban, C Fournier, M A Gougerot-Pocidalo, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Defective dendritic cell (DC) function in a HLA-B27 transgenic rat model of spondyloarthropathy (SpA)A J Stagg, M Breban, R E Hammer, et al.
Pageof 6